Common deficiencies of CMC dossiers for new drug applications of autologous CAR-T cell therapy medicinal products and key points to consider in review process

HAN Dong-mei, CUI Jing, WEI Wei

PDF(942 KB)
PDF(942 KB)
Chinese Journal of New Drugs ›› 2025, Vol. 34 ›› Issue (6) : 619-624. DOI: 10.20251/j.cnki.1003-3734.2025.06.011

Common deficiencies of CMC dossiers for new drug applications of autologous CAR-T cell therapy medicinal products and key points to consider in review process

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}. {{journal.qiKanMingCheng_EN}}. 2025, 34(6): 619-624 https://doi.org/10.20251/j.cnki.1003-3734.2025.06.011

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(942 KB)

Accesses

Citation

Detail

Sections
Recommended

/